M. Adli, . Ch, A. Baethge, N. Heinz, M. Langlitz et al., Is dose escalation of antidepressants a rational strategy after a medium???dose treatment has failed?, European Archives of Psychiatry and Clinical Neuroscience, vol.19, issue.6, pp.387-400, 2005.
DOI : 10.1002/cpt1976196795

". Alexanian_jb and . Pdf, AccessedFebruary 12, 2017.

G. S. Alexopoulos, C. M. Canuso, G. M. Gharabawi, C. A. Bossie, A. Greenspan et al., Placebo-ControlledStudy of Relapse PreventionWithRisperidone Augmentation in Older Patients withResistantDepression

G. Allouche, Prescriptions s??quentielles??: arguments en faveur d???une modification des sch??mas th??rapeutiques dans les d??pressions r??sistantes, L'Enc??phale, vol.42, issue.1, pp.32-38, 2016.
DOI : 10.1016/j.encep.2015.07.008

. Appelhof, C. Bente, P. Jantien, R. Brouwer, . Van-dyck et al., Triiodothyronine Addition to Paroxetine in the Treatment of Major Depressive Disorder, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.12, pp.6271-762004, 2004.
DOI : 10.1210/jc.2004-1147

M. Bauer, T. Bschor, D. Kunz, A. Berghöfer, A. Ströhle et al., Double-Blind, Placebo-Controlled Trial of the Use of Lithium to Augment Antidepressant Medication in Continuation Treatment of Unipolar Major Depression, American Journal of Psychiatry, vol.157, issue.9, pp.1429-1464, 2000.
DOI : 10.1176/appi.ajp.157.9.1429

M. Bauer and S. Dopfmer, Lithium Augmentation in Treatment-ResistantDepression: Meta- Analysis of Placebo-ControlledStudies, Journal of ClinicalPsychopharmacology, vol.19, issue.5, pp.427-461, 1999.

R. M. Berman, M. Fava, M. E. Thase, M. H. Trivedi, R. Swanink et al., ABSTRACT, CNS Spectrums, vol.154, issue.04, pp.197-206, 2009.
DOI : 10.1192/bjp.154.5.672

P. Blier, H. E. Ward, P. Tremblay, L. Laberge, C. Hébert et al., Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study, American Journal of Psychiatry, vol.167, issue.3, pp.281-88, 2010.
DOI : 10.1176/appi.ajp.2009.09020186

L. L. Carpenter, S. Yasmin, H. Lawrence, and . Price, A Double-Blind, Placebo- ControlledStudy of AntidepressantAugementationwith Mirtazapine, BiologicalPsychiatry, vol.51, issue.201, pp.183-88, 2002.

J. T. Cavanagh, A. J. Carson, M. Sharpe, and S. M. Lawrie, PsychologicalAutopsyStudies of Suicide: A SystematicReview, PsychologicalMedicine, vol.33, issue.3, pp.395-405, 2003.

. Chen, S. C. Yuan-who, and . Dilsaver, Lifetime Rates of Suicide AttemptsamongSubjectswithBipolar and UnipolarDisorders Relative to SubjectswithOther Axis I Disorders, BiologicalPsychiatry, vol.39, issue.10, pp.896-99, 1996.

A. Cipriani, T. L. Ferla, A. Toshi, A. Furukawa, . Signoretti et al., Sertraline versus OtherAntidepressive Agents for Depression, Cochrane Database of SystematicReviews, 2009.
DOI : 10.1002/14651858.cd006117.pub4

URL : http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006117.pub4/pdf

A. Cipriani, H. Pretty, K. Hawton, and J. R. Geddes, Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials, American Journal of Psychiatry, vol.162, issue.10, pp.1805-1824, 2005.
DOI : 10.1176/appi.ajp.162.10.1805

A. Cipriani, C. Santilli, A. Toshi, A. Furukawa, . Signoretti et al., Escitalopram versus OtherAntidepressive Agents for Depression, Cochrane Database of SystematicReviews, 2009.
DOI : 10.1002/14651858.cd006532.pub2

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164382/pdf

A. Cipriani, A. Katharine, . Smith, S. Sally, . Burgess et al., Lithium versus Antidepressants in the Long-TermTreatment of Unipolar Affective Disorder, Cochrane Database of SystematicReviews, 2006.

R. Cooper-kazaz, J. T. Apter, L. Cohen, . Karagichev, D. Saidmuhammed-moussa et al., Combined Treatment With Sertraline and Liothyronine in Major Depression, Archives of General Psychiatry, vol.64, issue.6, pp.679-88, 2007.
DOI : 10.1001/archpsyc.64.6.679

URL : http://archpsyc.jamanetwork.com/data/journals/psych/11844/yoa60092_679_688.pdf

R. Cooper-kazaz and B. Lerer, Efficacy and Safety of TriiodothyronineSupplementation in Patients with Major DepressiveDisorderTreatedwithSpecificSerotoninReuptakeInhibitors, The International Journal of Neuropsychopharmacology, vol.11, issue.05, 2008.

N. Crossley, M. Andres, and . Bauer, Acceleration and Augmentation of AntidepressantsWith Lithium for DepressiveDisorders:Two Meta-Analyses of Randomized, Placebo-Controlled Trials, The Journal of ClinicalPsychiatry, vol.68, issue.06, pp.935-975, 2007.

O. Doumy, D. Bennabi, W. El-hage, R. Najiballaïli, F. Bation et al., D??pression r??sistante??: les strat??gies de potentialisation, La Presse M??dicale, vol.45, issue.3, pp.338-387, 2016.
DOI : 10.1016/j.lpm.2016.02.004

. Electro and . Pdf, AccessedFebruary 12, 2017.

Y. Fang, C. Yuan, Y. Xu-chen, Z. Wu, L. Cao et al., A Pilot Study of the Efficacy and Safety of Paroxetine AugmentedWithRisperidone, Valproate, Buspirone, Trazodone, or Thyroid Hormone in AdultChinese Patients WithTreatment-Resistant Major Depression, Journal of ClinicalPsychopharmacology, 2011.

M. Ferreri, F. Lavergne, I. Berlin, C. Payan, and A. J. Puech, BenefitsfromMianserin Augmentation of Fluoxetine in Patients with Major Depression Non-Responders to

. Fluoxetinealone, Mianserin Augmentation of Fluoxetine, Acta PsychiatricaScandinavica, vol.103, issue.1, pp.66-72, 2008.

J. Gandara, L. Aguera, J. E. Rojo, S. Ros, and J. M. Pedro, Use of antidepressant combinations: which, when and why? Results of a Spanish survey, Acta Psychiatrica Scandinavica, vol.64, issue.1, pp.32-35, 2005.
DOI : 10.1016/S0197-2456(03)00112-0

A. Garakani, J. M. Martinez, S. Marcus, J. Weaver, K. Rickels et al., A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder, International Clinical Psychopharmacology, vol.23, issue.5, pp.269-75, 2008.
DOI : 10.1097/YIC.0b013e328301a74c

M. García-toro, A. Pascual-leone, M. Romera, A. González, J. Micó et al., Prefrontal repetitive transcranial magnetic stimulation as add on treatment in depression, Journal of Neurology, Neurosurgery & Psychiatry, vol.71, issue.4, pp.546-594, 2001.
DOI : 10.1136/jnnp.71.4.546

S. J. Garlow, W. Boadie, P. T. Dunlop, C. B. Ninan, and . Nemeroff, The Combination of Triiodothyronine (T3) and Sertraline Is Not Superior to Sertraline Monotherapy in the Treatment of Major DepressiveDisorder, Journal of PsychiatricResearch, vol.46, issue.11, pp.1406-1419, 2012.

G. M. Goodwin, F. G. Souza, and M. P. Austin, Lithium augmentation in antidepressant-resistant patients, The British Journal of Psychiatry, vol.161, issue.1, pp.128-157, 1992.
DOI : 10.1192/bjp.161.1.128b

D. P. Horgan, Beyond the Evidence: Is There a Place for AntidepressantCombinations in the Pharmacotherapy of Depression, The Medical Journal of Australia, vol.187, issue.3, pp.198-199, 2007.

D. Januel, G. Dumortier, C. Verdon, L. Stamatiadis, G. Saba et al., A Double-Blind ShamControlledStudy of Right PrefrontalRepetitiveTranscranialMagnetic Stimulation (rTMS):Therapeutic and Cognitive Effect in Medication Free UnipolarDepressionduring 4 Weeks, Progress in Neuro-Psychopharmacology&BiologicalPsychiatry, pp.126-156, 2006.

R. T. Joffe, W. Singer, A. J. Levitt, and C. Macdonald, A Placebo-Controlled Comparison of Lithium and Triiodothyronine Augmentation of Tricyclic Antidepressants in Unipolar Refractory Depression, Archives of General Psychiatry, vol.50, issue.5, pp.387-93, 1993.
DOI : 10.1001/archpsyc.1993.01820170065008

R. T. Joffe, T. H. Stephen, A. J. Sokolov, and . Levitt, Lithium and Triiodothyronine Augmentation of Antidepressants, The Canadian Journal of Psychiatry, vol.50, issue.12, pp.791-93, 2006.
DOI : 10.1001/archpsyc.1993.01820170065008

C. H. Kellner, M. Fink, R. Knapp, M. Georgiospetrides, T. Husain et al., Relief of Expressed Suicidal Intent by ECT: A Consortium for Research in ECT Study, American Journal of Psychiatry, vol.162, issue.5, pp.977-82, 2005.
DOI : 10.1176/appi.ajp.162.5.977

S. H. Kennedy, F. Henning, M. E. Andersen, and . Thase, Escitalopram in the Treatment of Major DepressiveDisorder: A Meta-Analysis, CurrentMedicalResearch and Opinion, vol.25, issue.1, pp.161-75, 2009.

. Ravindran, Canadian Network for Mood and AnxietyTreatments (CANMAT) Clinical Guidelines for the Management of Major DepressiveDisorder in Adults, Journal of Affective Disorders, vol.117, 2009.

. Feinsod, TherapeuticEfficacy of Right Prefrontal Slow RepetitiveTranscranialMagnetic Stimulation in Major Depression: A Double-Blind ControlledStudy, Archives of General Psychiatry, vol.56, issue.4, pp.315-335, 1999.

K. Komossa, M. Anna, A. Depping, W. Gaudchau, S. Kissling et al., Second-GenerationAntipsychotics for Major DepressiveDisorder and Dysthymia, Cochrane Database of SystematicReviews
DOI : 10.1002/14651858.cd008121.pub2

Y. Lecrubier, P. Boyer, S. Turjanski, and W. Rein, Amisulpride versus imipramine and placebo in dysthymia and major depression, Journal of Affective Disorders, vol.43, issue.2, pp.95-103, 1997.
DOI : 10.1016/S0165-0327(96)00103-6

J. Lefaucheur, N. André-obadia, E. Poulet, H. Devanne, E. Haffen et al., Recommandations fran??aises sur l???utilisation de la stimulation magn??tique transcr??nienne r??p??titive (rTMS)??: r??gles de s??curit?? et indications th??rapeutiques, Neurophysiologie Clinique/Clinical Neurophysiology, vol.41, issue.5-6, pp.221-95, 2011.
DOI : 10.1016/j.neucli.2011.10.062

M. J. Canuso, G. M. Kujawa, and . Gharabawi-garibaldi, Risperidone for Treatment-Refractory Major DepressiveDisorder: A Randomized Trial, Annals of InternalMedicine, vol.147, issue.9, pp.593-602, 2007.

R. N. Marcus, D. Robert, W. H. Mcquade, D. Carson, M. Hennicken et al., The Efficacy and Safety of Aripiprazole as AdjunctiveTherapy in Major DepressiveDisorder: A Second Multicenter, Randomized, Double-Blind, Placebo- ControlledStudy, Journal of ClinicalPsychopharmacology, vol.28, issue.2, pp.156-65, 2008.

. Mdd and . Pdf, AccessedFebruary 10, 2017.

D. Mischoulon, A. A. Nierenberg, L. Kizilbash, J. F. Rosenbaum, and M. Fava, Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians, The Canadian Journal of Psychiatry, vol.43, issue.5, pp.476-81, 2000.
DOI : 10.1016/S0006-3223(98)90777-6

S. A. Montgomery, S. David, P. Baldwin, N. A. Blier, S. Fineberg et al., Which antidepressants have demonstrated superior efficacy? A review of the evidence, International Clinical Psychopharmacology, vol.22, issue.6, pp.323-352, 2007.
DOI : 10.1097/YIC.0b013e3282eff7e0

G. Moore, G. Burford, and K. Lederis, Properties of urophysial proteins (urophysins) from the white sucker, Catostomus commersoni, Molecular and Cellular Endocrinology, vol.3, issue.4, pp.297-307, 1975.
DOI : 10.1016/0303-7207(75)90011-8

C. B. Nemeroff, R. Entsuah, I. Benattia, M. Demitrack, D. M. Sloan et al., ComprehensiveAnalysis of Remission (COMPARE) with Venlafaxine versus SSRIs, BiologicalPsychiatry, vol.63, issue.4, pp.424-458, 2008.
DOI : 10.1016/j.biopsych.2007.06.027

O. 'reardon, J. P. , H. Brent-solvason, P. G. Janicak, K. E. Shirlenesampson et al., Efficacy and Safety of TranscranialMagnetic Stimulation in the Acute Treatment of Major Depression: A MultisiteRandomizedControlled Trial, BiologicalPsychiatry, vol.62, issue.11, pp.1208-1224, 2007.

U. Osby, L. Brandt, N. Correia, A. Ekbom, and P. Sparén, Excess Mortality in Bipolar and Unipolar Disorder in Sweden, Archives of General Psychiatry, vol.58, issue.9, pp.844-50, 2001.
DOI : 10.1001/archpsyc.58.9.844

E. Poulet, J. Lefaucheur, N. André-obadia, and H. Devanne, Recommandations françaises sur l'utilisation de la stimulation magnétique transcrânienne répétitive (rTMS): règles de sécurité et indications thérapeutiques, 2011.

H. Reeves, S. Batra, R. S. May, R. Zhang, D. C. Dahl et al., Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major DepressiveDisorder: A Randomized, Double-Blind, Placebo- Controlled Pilot Study, The Journal of ClinicalPsychiatry, vol.69, issue.8, pp.1228-1264, 2008.

P. Rocca, V. Fonzo, L. Ravizza, G. Rocca, M. Scotta et al., A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder, Journal of Affective Disorders, vol.70, issue.3, pp.313-330, 2002.
DOI : 10.1016/S0165-0327(01)00327-5

A. Rush, M. H. John, J. W. Trivedi, A. A. Stewart, M. Nierenberg et al., Acute and Long-TermOutcomes of a Single- Blind RandomizedStudy, CombiningMedications to EnhanceDepressionOutcomes (CO-MED American Journal of Psychiatry, vol.168, issue.7, pp.689-701, 2011.

E. Smeraldi, Amisulpride versus Fluoxetine in Patients withDysthymia or Major Depression in Partial Remission A Double-Blind, Comparative Study, Journal of Affective Disorders, vol.4897, issue.1, pp.47-56, 1998.

L. Tarsitani and M. Pasquini, Compared with fluoxetine monotherapy, mirtazapine plus venlafaxine or fluoxetine increase remission but not response in patients with major depressive disorder, Evidence-Based Mental Health, vol.13, issue.3, pp.83-83, 2010.
DOI : 10.1136/ebmh1061

M. H. Trivedi, M. Fava, S. R. Wisniewski, M. E. Thase, F. Quitkin et al., Medication Augmentation after the Failure of SSRIs for Depression, New England Journal of Medicine, vol.354, issue.12, pp.1243-5210, 1056.
DOI : 10.1056/NEJMoa052964

N. Watanabe, I. M. Omori, A. Atsuonakagawa, . Cipriani, H. Corradobarbui et al., Furukawa, and Multiple Meta-Analyses of New GenerationAntidepressants (MANGA) Study Group Mirtazapine versus OtherAntidepressants in the Acute-Phase Treatment of Adultswith Major Depression:SystematicReview and Meta-Analysis, The Journal of ClinicalPsychiatry, vol.69, issue.9, pp.1404-1419, 2008.